Report overview
This report contains market size and forecasts of Biopharmaceutical Oral Drug Delivery in global, including the following market information:
Global Biopharmaceutical Oral Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biopharmaceutical Oral Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biopharmaceutical Oral Drug Delivery companies in 2021 (%)
The global Biopharmaceutical Oral Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Normally Protein (Antibodies) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical Oral Drug Delivery include AbbVie, Amgen, Catalent, Kemwell Bipharma, Pfizer, Novartis, Biocon, Sanofi and F. Hoffman-La Roche and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical Oral Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical Oral Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biopharmaceutical Oral Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Normally Protein (Antibodies)
Nucleic Acids (DNA, RNA Or Oligonucleotides)
Global Biopharmaceutical Oral Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biopharmaceutical Oral Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Specialty Pharmacy
Global Biopharmaceutical Oral Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biopharmaceutical Oral Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biopharmaceutical Oral Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biopharmaceutical Oral Drug Delivery revenues share in global market, 2021 (%)
Key companies Biopharmaceutical Oral Drug Delivery sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biopharmaceutical Oral Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Catalent
Kemwell Bipharma
Pfizer
Novartis
Biocon
Sanofi
F. Hoffman-La Roche
Novo Nordisk
